NM_001145668.2:c.*1765C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001145668.2(CTXN2):​c.*1765C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.843 in 167,026 control chromosomes in the GnomAD database, including 63,613 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.83 ( 56211 hom., cov: 31)
Exomes 𝑓: 1.0 ( 7402 hom. )

Consequence

CTXN2
NM_001145668.2 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.349

Publications

7 publications found
Variant links:
Genes affected
CTXN2 (HGNC:31109): (cortexin 2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
SLC12A1 (HGNC:10910): (solute carrier family 12 member 1) This gene encodes a kidney-specific sodium-potassium-chloride cotransporter that is expressed on the luminal membrane of renal epithelial cells of the thick ascending limb of Henle's loop and the macula densa. It plays a key role in concentrating urine and accounts for most of the NaCl resorption. It is sensitive to such diuretics as furosemide and bumetanide. Some Bartter-like syndromes result from defects in this gene. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their biological validity in humans has not been experimentally proven.[provided by RefSeq, May 2010]
SLC12A1 Gene-Disease associations (from GenCC):
  • Bartter disease type 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • antenatal Bartter syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTXN2NM_001145668.2 linkc.*1765C>T 3_prime_UTR_variant Exon 2 of 2 ENST00000417307.3 NP_001139140.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTXN2ENST00000417307.3 linkc.*1765C>T 3_prime_UTR_variant Exon 2 of 2 1 NM_001145668.2 ENSP00000406145.2

Frequencies

GnomAD3 genomes
AF:
0.828
AC:
125894
AN:
151990
Hom.:
56201
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.477
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.922
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
0.588
Gnomad SAS
AF:
0.845
Gnomad FIN
AF:
0.998
Gnomad MID
AF:
0.991
Gnomad NFE
AF:
0.998
Gnomad OTH
AF:
0.872
GnomAD4 exome
AF:
0.996
AC:
14860
AN:
14918
Hom.:
7402
Cov.:
0
AF XY:
0.996
AC XY:
7066
AN XY:
7094
show subpopulations
African (AFR)
AF:
0.750
AC:
3
AN:
4
American (AMR)
AF:
0.833
AC:
5
AN:
6
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.500
AC:
2
AN:
4
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.997
AC:
14651
AN:
14702
Middle Eastern (MID)
AF:
1.00
AC:
4
AN:
4
European-Non Finnish (NFE)
AF:
0.981
AC:
102
AN:
104
Other (OTH)
AF:
0.989
AC:
93
AN:
94
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.828
AC:
125939
AN:
152108
Hom.:
56211
Cov.:
31
AF XY:
0.829
AC XY:
61675
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.476
AC:
19733
AN:
41414
American (AMR)
AF:
0.922
AC:
14090
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3469
AN:
3470
East Asian (EAS)
AF:
0.589
AC:
3044
AN:
5170
South Asian (SAS)
AF:
0.846
AC:
4071
AN:
4810
European-Finnish (FIN)
AF:
0.998
AC:
10593
AN:
10618
Middle Eastern (MID)
AF:
0.990
AC:
291
AN:
294
European-Non Finnish (NFE)
AF:
0.998
AC:
67910
AN:
68028
Other (OTH)
AF:
0.864
AC:
1826
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
707
1413
2120
2826
3533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.871
Hom.:
28727
Bravo
AF:
0.807
Asia WGS
AF:
0.634
AC:
2210
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.1
DANN
Benign
0.36
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1320052; hg19: chr15-48495508; COSMIC: COSV57711825; COSMIC: COSV57711825; API